Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/1557"
| Predicate | Value (sorted: none) |
|---|---|
| rdf:type | |
| rdf:type | |
| rdfs:label |
"evidence_1524"
|
| ?:Evidence_type | |
| ?:Evidence_object_dose | |
| ?:Evidence_precip_dose | |
| ?:Evidence_value |
"0.94"
|
| dc:creator | |
| dc:date |
"04/25/2012 13:27:05"
|
| ?:content |
"NOTE: AUC_i/AUC is from Table IV. The object_dose listed is the average dose.
route of administration: oral (olanzapine)/transdermal patch (selegiline)
study duration: 10 days
population: 12 healthy male and female volunteers, 5 male and 7 female (2 white, 6 black, 3 Hispanic, 1 other race)
tested for known CYP450 polymorphisms?
NO
ages: 18-45"
|
| rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ olanzapine_increases_auc_selegiline, <http://purl.org/swan/1.2/swan-commons#citesAsRefutingEvidence>, evidence_1524 }